Job Details
Do you pride yourself on your integrity? We do what’s right for our employees, patients and partners so can you?
We are looking to appoint Team Leaders to lead Engineering teams across multiple sites. The role will develop, manage, lead and coach the team in line with OXB’s Engineering, Quality, Safety and Environmental systems and procedures. Ensuring adherence to external regulatory standards.
Oxford Biomedica’s Engineering team are responsible for all aspects of Plant, Mechanical, Electrical, and Incoming utilities at our facilities.
Your responsibilities in this role would be:
- Responsible for the performance of a multi-disciplinary Engineering Team against internal customer expectations and agreed service levels.
- Lead/Drive continuous Improvement of engineering processes and procedures across both direct reports and department.
- Responsible for the line & performance management of Engineers within a defined team including their training and development.
- Define and support engineering projects relating to both operational and capital expenditure.
- Engineering team resource scheduling and adherence to planned maintenance and calibration schedules.
- Participate and lead root cause analysis investigations using a systematic approach to resolve complex and technical problems, implementing suitable and sustainable solutions. Ensuring quality documents are completed and progressed in line with internal procedures.
- Engineering related contractor selection and contract management.
- Identify and lead asset criticality assessments, planned preventative maintenance, calibration standards across all business assets.
- Delivery of collaborative solutions by establishing and maintaining good working.
Profile description:
We are looking for:
- A minimum of 5 GCSE’s (or equivalent) including Maths and English
- An apprenticeship within a relevant discipline, NVQ 3 Level 3, City & Guilds or equivalent is preferred.
- Mechanical and/or Electrical knowledge of associated equipment within a regulated environment.
- Proven experience within an engineering maintenance function.
- Experience within a GxP Pharmaceutical/Biotech industry is preferred.
- Extensive knowledge of industry standards, regulatory, legal, and ethical framework in relation to engineering and facilities.
- A good understanding of environmental, health and safety at work regulations.
- The ability to manage a team inclusive of people management.
- The ability to build cross departmental relationships to support the objective of the function.
About Us:
We are a quality and innovation-led cell and gene therapy CDMO with a mission to enable our clients to deliver life changing therapies to patients around the world. Our innovative solutions and proven expertise allow our clients in the biotech and biopharma industry, to deliver life-saving therapies to reach even more patients. The success of cell and gene therapy products transforms outcomes for millions of people suffering from some of the world’s worst diseases and medical conditions.
What’s in it for you:
- Highly competitive reward packages
- Wellbeing programmes
- Development opportunities
- A 35-hour working week.
- Welcoming, friendly, supportive colleagues
- A diverse and inclusive working environment
- Our values are: Deliver Innovation, Be Inspiring and Have Integrity
- State of the art laboratory and manufacturing facilities
We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment, and teamwork, and so can you.
Collaborate. Contribute. Change lives.
We offer:
Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).
Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.